Funding
← Back to your selection

Wallonie Entreprendre

Activity from announced rounds

Activity in this selectionAI

Wallonie Entreprendre is the public investor identified through its Enodia announcement and Chift and Novadip coverage.

Recorded funding activity

Enodia develops protein-degradation medicines. Chift connects financial software APIs, while Novadip develops regenerative cell therapies. W.IN.G and named regional funds remain distinct from the public investor.

Sources
Rounds participated in
2
Confirmed lead rounds
0
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$36.3M
2 disclosed · full round size, not this investor’s share

By stage

Seed1
Series A1

By primary sector

Biotech1
Fintech1

By country

Belgium1
France1

Rounds

2 in this selection
Chift

A unified API that lets software companies and AI agents connect to accounting, payment, point-of-sale, ecommerce and other financial tools across Europe.

€10.5MSeries A
Participant
Enodia Therapeutics

Develops small-molecule therapies for targeted protein degradation at the point of synthesis

Role not disclosed